Livingston HealthCare is pleased to announce that Deb Anczak has been named as Chief Executive Officer. Anczak has served as Interim CEO at LHC since January 2018.
Anczak came to LHC in 2011 as pharmacy manager. In 2014, she took on the
role of Director of Performance Improvement and held both of these positions
until taking over as Interim CEO.
“We couldn’t be more pleased to have found such an exceptional match for this position internally,” said Denis Prager, Chair of the LHC Board of Directors. “Deb brings new ideas and fresh perspective to the organization, combined with first-hand knowledge of its day-today operations. She will continue Livingston HealthCare’s forward momentum and help propel us to the next level.”
“I am honored to step into the role of CEO at Livingston HealthCare,” said Anczak. “Our team here is outstanding and I am excited to work together to achieve the goals outlined in our strategic plan. Providing exceptional, patient-centered care for our community will remain at the center of all we do.”
Anczak received a Bachelor of Science degree in pharmacy from the University of Wisconsin-Madison and a master’s degree in health services administration from University of St. Francis in Joliet, Illinois.